MHCD:CA:TSX-Middlefield Healthcare Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 11.62

Change

0.00 (0.00)%

Market Cap

CAD 0.16B

Volume

673.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.10 (+0.38%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

-0.11 (-0.32%)

CAD 5.85B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.48B
PHYS-U:CA Sprott Physical Gold Trust

N/A

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.28 (-0.74%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.16 (-0.36%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.20 (-0.83%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.10 (-1.01%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.98B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B

ETFs Containing MHCD:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.40% 40% F 42% F
Dividend Return 4.66% 77% C+ 66% D+
Total Return 13.06% 45% F 45% F
Trailing 12 Months  
Capital Gain 8.80% 41% F 42% F
Dividend Return 4.68% 77% C+ 66% D+
Total Return 13.48% 46% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.46% 48% F 43% F
Dividend Return 2.75% 49% F 37% F
Total Return 0.29% 65% D 25% F
Risk Return Profile  
Volatility (Standard Deviation) 6.15% 75% C 88% B+
Risk Adjusted Return 44.70% 60% D- 59% D-
Market Capitalization 0.16B 73% C 42% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.